"Weight Management in the United Kingdom" Now Available at Fast Market Research
Retail sales of weight management products in the UK declined by 2% in current value terms in 2011, to GBP126 million. The sharp slump of GlaxoSmithKline Plc's OTC obesity pill Alli (value sales decline of 20%) had a major impact on the category. Excluding Alli's OTC obesity, weight management enjoyed current value growth of 3% in 2011. This reflects a feeling expressed in trade interviews that notwithstanding its more recent loss of market credibility, the product has helped to attract...
View full press release